International consultation on urologic diseases and the European association of urology international consultation on locally advanced renal cell carcinoma

Vitaly Margulis, Viraj A. Master, Nicholas G. Cost, Bradley C. Leibovich, Steven Joniau, Markus Kuczyk, Peter F. Mulders, Ziya Kirkali, Manfred P. Wirth, Yoshihiko Hirao, Sudhir Rawal, Tsung Wen Chong, Christopher G. Wood

Research output: Contribution to journalReview article

20 Citations (Scopus)

Abstract

Context: Although an ever-increasing number of patients are being incidentally diagnosed with small renal masses, there is still a sizable portion of patients with renal cell carcinoma (RCC) who present with locally advanced or metastatic disease. Those with locally advanced disease present a challenge because they may be difficult to distinguish from those with organ-confined disease at the time of diagnosis. However, this distinction is important because they may require a different management strategy. These advanced RCC patients include those with venous tumour thrombi, extracapsular tumour extension, adjacent organ involvement, as well as nodal disease. Evidence acquisition: A thorough literature search of the following terms was undertaken: advanced renal cell carcinoma, renal cell carcinoma venous tumour thrombi, renal cell carcinoma extra-capsular extension, renal cell carcinoma nodal metastasis, and locally recurrent renal cell carcinoma. An international expert panel convened by the International Consultation on Urologic Diseases and the European Association of Urology reviewed these articles. Evidence synthesis: Review of the available literature allowed for assessment of the level of evidence for the diagnosis, management, and therapy of locally advanced RCC with the ultimate goal of providing a synthesis of this information with a consensus statement from leaders in the field. Conclusions: Despite the advances in prognostic markers and targeted molecular therapies for RCC, currently the only curative treatment for locally advanced RCC is aggressive surgical resection.

Original languageEnglish (US)
Pages (from-to)673-683
Number of pages11
JournalEuropean Urology
Volume60
Issue number4
DOIs
StatePublished - Oct 2011

Fingerprint

Urologic Diseases
Urology
Renal Cell Carcinoma
Referral and Consultation
Thrombosis
Molecular Targeted Therapy
Neoplasms
Neoplasm Metastasis
Kidney

Keywords

  • Consensus statements
  • Local advanced renal cell carcinoma
  • Renal cell carcinoma

ASJC Scopus subject areas

  • Medicine(all)
  • Urology

Cite this

International consultation on urologic diseases and the European association of urology international consultation on locally advanced renal cell carcinoma. / Margulis, Vitaly; Master, Viraj A.; Cost, Nicholas G.; Leibovich, Bradley C.; Joniau, Steven; Kuczyk, Markus; Mulders, Peter F.; Kirkali, Ziya; Wirth, Manfred P.; Hirao, Yoshihiko; Rawal, Sudhir; Chong, Tsung Wen; Wood, Christopher G.

In: European Urology, Vol. 60, No. 4, 10.2011, p. 673-683.

Research output: Contribution to journalReview article

Margulis, V, Master, VA, Cost, NG, Leibovich, BC, Joniau, S, Kuczyk, M, Mulders, PF, Kirkali, Z, Wirth, MP, Hirao, Y, Rawal, S, Chong, TW & Wood, CG 2011, 'International consultation on urologic diseases and the European association of urology international consultation on locally advanced renal cell carcinoma', European Urology, vol. 60, no. 4, pp. 673-683. https://doi.org/10.1016/j.eururo.2011.06.042
Margulis, Vitaly ; Master, Viraj A. ; Cost, Nicholas G. ; Leibovich, Bradley C. ; Joniau, Steven ; Kuczyk, Markus ; Mulders, Peter F. ; Kirkali, Ziya ; Wirth, Manfred P. ; Hirao, Yoshihiko ; Rawal, Sudhir ; Chong, Tsung Wen ; Wood, Christopher G. / International consultation on urologic diseases and the European association of urology international consultation on locally advanced renal cell carcinoma. In: European Urology. 2011 ; Vol. 60, No. 4. pp. 673-683.
@article{304f95b232d84b41bed88ba8648091c4,
title = "International consultation on urologic diseases and the European association of urology international consultation on locally advanced renal cell carcinoma",
abstract = "Context: Although an ever-increasing number of patients are being incidentally diagnosed with small renal masses, there is still a sizable portion of patients with renal cell carcinoma (RCC) who present with locally advanced or metastatic disease. Those with locally advanced disease present a challenge because they may be difficult to distinguish from those with organ-confined disease at the time of diagnosis. However, this distinction is important because they may require a different management strategy. These advanced RCC patients include those with venous tumour thrombi, extracapsular tumour extension, adjacent organ involvement, as well as nodal disease. Evidence acquisition: A thorough literature search of the following terms was undertaken: advanced renal cell carcinoma, renal cell carcinoma venous tumour thrombi, renal cell carcinoma extra-capsular extension, renal cell carcinoma nodal metastasis, and locally recurrent renal cell carcinoma. An international expert panel convened by the International Consultation on Urologic Diseases and the European Association of Urology reviewed these articles. Evidence synthesis: Review of the available literature allowed for assessment of the level of evidence for the diagnosis, management, and therapy of locally advanced RCC with the ultimate goal of providing a synthesis of this information with a consensus statement from leaders in the field. Conclusions: Despite the advances in prognostic markers and targeted molecular therapies for RCC, currently the only curative treatment for locally advanced RCC is aggressive surgical resection.",
keywords = "Consensus statements, Local advanced renal cell carcinoma, Renal cell carcinoma",
author = "Vitaly Margulis and Master, {Viraj A.} and Cost, {Nicholas G.} and Leibovich, {Bradley C.} and Steven Joniau and Markus Kuczyk and Mulders, {Peter F.} and Ziya Kirkali and Wirth, {Manfred P.} and Yoshihiko Hirao and Sudhir Rawal and Chong, {Tsung Wen} and Wood, {Christopher G.}",
year = "2011",
month = "10",
doi = "10.1016/j.eururo.2011.06.042",
language = "English (US)",
volume = "60",
pages = "673--683",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - International consultation on urologic diseases and the European association of urology international consultation on locally advanced renal cell carcinoma

AU - Margulis, Vitaly

AU - Master, Viraj A.

AU - Cost, Nicholas G.

AU - Leibovich, Bradley C.

AU - Joniau, Steven

AU - Kuczyk, Markus

AU - Mulders, Peter F.

AU - Kirkali, Ziya

AU - Wirth, Manfred P.

AU - Hirao, Yoshihiko

AU - Rawal, Sudhir

AU - Chong, Tsung Wen

AU - Wood, Christopher G.

PY - 2011/10

Y1 - 2011/10

N2 - Context: Although an ever-increasing number of patients are being incidentally diagnosed with small renal masses, there is still a sizable portion of patients with renal cell carcinoma (RCC) who present with locally advanced or metastatic disease. Those with locally advanced disease present a challenge because they may be difficult to distinguish from those with organ-confined disease at the time of diagnosis. However, this distinction is important because they may require a different management strategy. These advanced RCC patients include those with venous tumour thrombi, extracapsular tumour extension, adjacent organ involvement, as well as nodal disease. Evidence acquisition: A thorough literature search of the following terms was undertaken: advanced renal cell carcinoma, renal cell carcinoma venous tumour thrombi, renal cell carcinoma extra-capsular extension, renal cell carcinoma nodal metastasis, and locally recurrent renal cell carcinoma. An international expert panel convened by the International Consultation on Urologic Diseases and the European Association of Urology reviewed these articles. Evidence synthesis: Review of the available literature allowed for assessment of the level of evidence for the diagnosis, management, and therapy of locally advanced RCC with the ultimate goal of providing a synthesis of this information with a consensus statement from leaders in the field. Conclusions: Despite the advances in prognostic markers and targeted molecular therapies for RCC, currently the only curative treatment for locally advanced RCC is aggressive surgical resection.

AB - Context: Although an ever-increasing number of patients are being incidentally diagnosed with small renal masses, there is still a sizable portion of patients with renal cell carcinoma (RCC) who present with locally advanced or metastatic disease. Those with locally advanced disease present a challenge because they may be difficult to distinguish from those with organ-confined disease at the time of diagnosis. However, this distinction is important because they may require a different management strategy. These advanced RCC patients include those with venous tumour thrombi, extracapsular tumour extension, adjacent organ involvement, as well as nodal disease. Evidence acquisition: A thorough literature search of the following terms was undertaken: advanced renal cell carcinoma, renal cell carcinoma venous tumour thrombi, renal cell carcinoma extra-capsular extension, renal cell carcinoma nodal metastasis, and locally recurrent renal cell carcinoma. An international expert panel convened by the International Consultation on Urologic Diseases and the European Association of Urology reviewed these articles. Evidence synthesis: Review of the available literature allowed for assessment of the level of evidence for the diagnosis, management, and therapy of locally advanced RCC with the ultimate goal of providing a synthesis of this information with a consensus statement from leaders in the field. Conclusions: Despite the advances in prognostic markers and targeted molecular therapies for RCC, currently the only curative treatment for locally advanced RCC is aggressive surgical resection.

KW - Consensus statements

KW - Local advanced renal cell carcinoma

KW - Renal cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=80052272210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80052272210&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2011.06.042

DO - 10.1016/j.eururo.2011.06.042

M3 - Review article

C2 - 21752533

AN - SCOPUS:80052272210

VL - 60

SP - 673

EP - 683

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 4

ER -